Visit our country sites
- Visit our country sites
- CEVA corporate
- CEVA group web sites
Ceva Animal Health has been ranked as one of the top three fastest-growing veterinary pharmaceutical companies in the world for the past five years¹. We now rank as the ninth largest animal health group globally – and we were only founded in 1991! Our expertise centers on the two fields of pharmacology and biology, where we have dedicated teams that aim to meet the specific demands of the livestock, poultry, swine and pet sectors. We continually strive to find better solutions to existing and emerging diseases which, in turn, improve animal health and productivity.
Our care extends beyond animal welfare. These days, a staggering 75% of all emerging human infectious diseases are of animal origin. Ceva is involved in the fight against the spread of infectious disease that can be transmitted from wild or domestic animals and birds to humans – diseases known as zoonoses – which include avian flu, brucellosis and Q-fever.
Ceva is a visible supporter of and contributor to various welfare and social programs all over the world. Our work ranges from researching, developing, producing and supplying animal health products to the poorest livestock owners in the world, (our SOS - Stamp Out Sleeping sickness - program in Uganda is a good example) to supplying the UK’s largest dog welfare charity with Dog Appeasing Pheromone (DAP) collars to help make the lives of shelter dogs less stressful.
Ceva successfully combines profitability with long-term growth.
Our global business operations are divided into six major zones: Western Europe, Central and Eastern Europe (incl. Turkey), North America, Latin America, Africa/Middle East and Asia/Pacific.
We are directly present in 40 countries, have 11 research and development centres, 17 production sites and 2 543 employees worldwide. The company is focused on the research, development, production and marketing of pharmaceutical products and vaccines for companion animal, poultry, ruminant and swine.
¹Vetnosis 2010, CAGR period 1999-2009